查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008769

幹細胞製造市場報告：按產品、應用、最終用戶和地區分類，2026-2034年

Stem Cell Manufacturing Market Report by Product, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年全球幹細胞生產市場規模達152億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到268億美元，2026年至2034年的複合年成長率為6.30%。推動市場成長的因素包括：幹細胞研究投資的增加、慢性病盛行率的上升、生物技術的進步、產學合作、嚴格的監管以及人們對幹細胞療法的認知不斷提高。

幹細胞製造市場的發展趨勢：

增加對幹細胞研究和再生醫學的投資

由於大量投資湧入幹細胞研究和再生醫學領域，全球幹細胞製造市場正經歷顯著成長。各國政府和私營機構紛紛加大對這些領域的投入，並認知到它們具有革新醫學的巨大潛力。這主要得益於幹細胞療法在治療以往難以治癒的疾病（例如神經退化性疾病和脊髓損傷）方面展現出的巨大前景。例如，2023年8月發表在《新英格蘭醫學雜誌》上的一篇論文重點介紹了幹細胞基因療法在治療鐮狀細胞疾病（SCD）方面的巨大潛力。這些投資正在支持前沿研究、先進製造技術的開發以及臨床試驗的擴展。例如，2021年9月，LifeCell International Pvt. Ltd.獲得了來自OrbiMed Asia Partners IV的22.5億盧比（約2720萬美元）投資，使其能夠進一步利用其技術專長和廣泛的網路，拓展到生育治療和細胞療法等相關新領域。此外，2023 年 11 月，美國一家專門從事重組蛋白和必需試劑的公司 ACROBiosystems Inc. 推出了 GM 級 DLL4 蛋白，這可溶性的Delta 樣配體 4 (DLL4)，對幹細胞的發育和分化至關重要。

慢性病發生率上升以及對創新治療方法的需求

推動全球幹細胞製造市場發展的另一個關鍵因素是慢性病盛行率的激增。糖尿病、心臟病和自體免疫疾病等疾病的發生率不斷上升，治療方法。幹細胞療法具有透過再生受損組織和器官來治療這些疾病的巨大潛力。例如，2021年3月，Vertex Pharmaceuticals公司獲得美國食品藥物管理局（FDA）授予的快速通道核准，其研發的VX-880是一種用於治療第1簡審類糖尿病的人類幹細胞衍生療法。此外，根據美國食品藥物管理局（FDA）2022年12月發布的數據，美國有超過7,000種罕見疾病，影響超過3,000萬人。慢性病的盛行率隨著老齡化的成長而增加，幹細胞製造技術被視為對抗這些疾病的強大武器。例如，根據世界衛生組織 (WHO) 2021 年 10 月的情況說明書，預計到 2030 年，全球 65 歲及以上人口數量將達到 14 億，到 2050 年將加倍，達到 22 億。

生物技術和細胞培養技術的進步

生物技術和細胞培養技術的進步正在革新幹細胞生產領域。這些進步對於提高幹細胞生產的效率和擴充性至關重要。細胞培養技術的突破性進展，例如3D細胞培養系統和生物反應器，使得大規模培養高品質幹細胞成為可能。此外，基因編輯技術的創新，例如CRISPR-Cas9，能夠精確控制幹細胞的特性，進一步擴大其治療潛力。這些進步不僅簡化了生產流程，還確保了幹細胞療法的安全性和質量，從而贏得了醫療專業人員和患者的信任。例如，2021年9月，專注於幹細胞生產的美國生物技術公司Cellino宣布了一項利用其專有系統提高產量並降低生產成本的方法。該系統整合了人工智慧、機器學習、雷射以及其他硬體和軟體。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球幹細胞製造市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 消耗品
    • 主要部分
      • 培養基
      • 其他
  • 裝置
    • 主要部分
      • 生物反應器培養箱
      • 細胞分選儀
      • 其他
  • 幹細胞株
    • 主要部分
      • 造血幹細胞（HSC）
      • 間質幹細胞（MSCs）
      • 誘導性多功能幹細胞（iPSCs）
      • 胚胎幹細胞（ESCs）
      • 神經幹細胞（NSCs）
      • 多功能成體祖細胞

第7章 市場區隔：依應用領域分類

  • 研究用途
    • 主要部分
      • 生命科學研究
      • 藥物發現與開發
  • 臨床應用
    • 主要部分
      • 異體幹細胞療法
      • 自體幹細胞療法
  • 細胞和組織庫的應用

第8章 市場區隔：依最終用戶分類

  • 製藥和生物技術公司
  • 學術機構、研究機構、合約研究組織
  • 醫院/外科中心
  • 細胞和組織庫
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • AcceGen
    • Bio-Rad Laboratories, Inc.
    • Cellular Engineering Technologies, Inc
    • Corning Incorporated
    • Lonza Group AG
    • REPROCELL Inc
    • Sartorius AG
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A6072

The global stem cell manufacturing market size reached USD 15.2 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 26.8 Billion by 2034 , exhibiting a growth rate (CAGR) of 6.30% during 2026-2034 . Increasing investments in stem cell research, rising chronic disease prevalence, advancements in biotechnology, collaborations between academia and industry, stringent regulations, and expanding awareness of stem cell therapies are stimulating the market growth.

STEM CELL MANUFACTURING MARKET ANALYSIS:

  • Major Market Drivers: Growing venture capital investment in stem cell research, supported by favorable government initiatives are majorly driving the stem cell manufacturing market. This, in turn, reflects the increasing recognition of stem cell's potential in advancing healthcare and regenerative medicine.
  • Key Market Trends: Some of the key trends in the stem cell manufacturing market include rising expenditure on stem cell research and regenerative medicine, automation of processes, increasing collaborations among industry players, and rapid advancements in bioreactor technology.
  • Geographical Trends: North America is leading the stem cell manufacturing market due to several factors, including the presence of leading biotechnology and pharmaceutical companies, a supportive regulatory framework towards clinical trials and commercialization of stem cell manufacturing, robust research and development (R&D) infrastructure, and the rising demand for regenerative medicine therapies in the region.
  • Competitive Landscape: Some of the major market players in the stem cell manufacturing industry include AcceGen, Bio-Rad Laboratories, Inc., Cellular Engineering Technologies, Inc, Corning Incorporated, Lonza Group AG, REPROCELL Inc, Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc., among many others.
  • Challenges and Opportunities: Government initiatives to boost the biotechnology and biopharmaceutical industries represent a significant opportunity for the market. Initiatives, such as grants, tax incentives, and subsidies, aim to promote R&D, attract investments, adopt advanced technologies, and accelerate scientific discoveries and innovations in therapies and treatments. However, the market also faces a significant challenge like technical limitations associated with manufacturing scale-up, which will require companies specialized equipment and infrastructure to overcome.

STEM CELL MANUFACTURING MARKET TRENDS:

Increasing Investments in Stem Cell Research and Regenerative Medicine

The global stem cell manufacturing market is experiencing a significant upsurge due to the substantial investments pouring into stem cell research and regenerative medicine. Governments and private organizations are channeling resources toward these fields, recognizing their potential to revolutionize healthcare. This driver is fueled by the promising prospects of stem cell therapies in addressing previously untreatable conditions, such as neurodegenerative diseases and spinal cord injuries. For instance, an article published in the New England Journal of Medicine in August 2023 revealed the anticipated potential of stem cell gene therapy in treating Sickle Cell Disease (SCD). These investments support cutting-edge research, the development of advanced manufacturing techniques, and the expansion of clinical trials. For example, in September 2021, LifeCell International Pvt. Ltd received an investment of INR 225 crore (USD 27.2 million) from OrbiMed Asia Partners IV to further leverage its technological expertise and wide network to foray into adjacent new categories like fertility health and cell-based therapeutics. Moreover, in November 2023, ACROBiosystems Inc., a US-based company specializing in recombinant proteins and essential reagents, launched GM-grade DLL4 protein, a soluble form of Delta-like Ligand 4 (DLL4), crucial in stem cell development and differentiation.

Rising Prevalence of Chronic Diseases and the Demand for Innovative Treatments

Another vital driver propelling the global stem cell manufacturing market is the escalating prevalence of chronic diseases. Conditions like diabetes, heart disease, and autoimmune disorders are on the rise, necessitating novel and effective treatments. Stem cell therapies hold immense promise in addressing these ailments by regenerating damaged tissues and organs. For instance, in March 2021, Vertex Pharmaceuticals received FDA grant as a fast track designation to VX-880, a human stem-cell derived therapy for patients with Type-1 diabetes. Moreover, as per the December 2022 data provided by the US Food and Drug Administration (FDA), there are over 7,000 rare diseases that affect more than 30 million people in the United States. The prevalence of chronic diseases rises with age, and stem cell manufacturing exhibits promise in combating these conditions. For example, a World Health Organization factsheet from October 2021 projects that globally there will be 1.4 billion people over the age of 65 by 2030 and this number is expected to double at 2.2 billion by 2050.

Advancements in Biotechnology and Cell Culture Techniques

Advancements in biotechnology and cell culture techniques are revolutionizing the field of stem cell manufacturing. This driver is pivotal in enhancing the efficiency and scalability of stem cell production. Breakthroughs in cell culture technology, such as 3D cell culture systems and bioreactors, enable the cultivation of high-quality stem cells in larger quantities. Additionally, innovations in genetic editing techniques, like CRISPR-Cas9, offer precise control over stem cell characteristics, further expanding their therapeutic potential. These advancements not only streamline the manufacturing process but also ensure the safety and quality of stem cell-based therapies, instilling confidence among healthcare professionals and patients alike. For instance, in September 2021, Cellino, a US-based biotech company with specialization in stem cell manufacturing, presented how its system integrates AI, machine learning, and lasers, along with other hardware and software, to enhance yields and reduce production costs.

STEM CELL MANUFACTURING MARKET SEGMENTATION:

Breakup by Product:

  • Consumables
    • Culture Media
    • Others
  • Instruments
    • Bioreactors and Incubators
    • Cell Sorters
    • Others
  • Stem Cell Lines
    • Hematopoietic Stem Cells (HSC)
    • Mesenchymal Stem Cells (MSC)
    • Induced Pluripotent Stem Cells (iPSC)
    • Embryonic Stem Cells (ESC)
    • Neural Stem Cells (NSC)
    • Multipotent Adult Progenitor Stem Cells

Consumables dominate the market

The consumables segment within the stem cell manufacturing market is experiencing robust growth due to the increasing adoption of stem cell-based research and therapies, necessitating a constant supply of consumables, including cell culture media, reagents, and growth factors. As research in this field expands, so does the demand for these essential materials. Moreover, the growing number of stem cell clinical trials and applications in regenerative medicine fuels the consumption of consumables. Clinical research and therapy development require a consistent and reliable source of high-quality consumables to ensure the safety and efficacy of stem cell-based treatments. In line with this, technological advancements in the production of consumables are driving growth.

Breakup by Application:

  • Research Applications
    • Life Science Research
    • Drug Discovery and Development
  • Clinical Application
    • Allogenic Stem Cell Therapy
    • Autologous Stem Cell Therapy
  • Cell and Tissue Banking Applications

Research applications dominate the market

The growth of the research applications segment within the stem cell manufacturing market is underpinned by the relentless pursuit of scientific knowledge and breakthrough discoveries in stem cell biology. Stem cells serve as essential tools for investigating various biological processes, disease mechanisms, and potential therapeutic avenues. Researchers across diverse fields, including regenerative medicine, developmental biology, and drug development, rely on stem cells to advance their studies. Moreover, the increasing funding and grants allocated to stem cell research bolster this segment's growth. Governments, private institutions, and non-profit organizations recognize the transformative potential of stem cell research and provide financial support to drive innovation. Additionally, technological advancements in stem cell culture techniques, genetic editing, and cell characterization tools enhance the efficiency and accuracy of research applications. These advancements enable researchers to work with a broader range of stem cell types and manipulate them with precision, further expanding the scope of research possibilities. For instance, in May 2023, Sernova announced research collaboration with AstraZeneca to evaluate novel potential therapeutic cell applications.

Breakup by End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes, Research Laboratories and Contract Research Organizations
  • Hospitals and Surgical Centers
  • Cell and Tissue banks

Pharmaceutical & biotechnology companies dominate the market

The growth of pharmaceutical and biotechnology companies is propelled by the continuous expansion of the global population and the aging demographic trends. With an aging population, the demand for healthcare services, medications, and innovative therapies rises, providing a substantial market for pharmaceutical and biotechnology companies to cater to. Moreover, the increasing prevalence of chronic diseases, including cardiovascular disorders, cancer, and diabetes, necessitates ongoing research and the development of new pharmaceutical solutions. These companies play a pivotal role in creating advanced drugs and therapies to combat these health challenges. Furthermore, advancements in biotechnology, including gene therapy, precision medicine, and biopharmaceuticals, are shaping the industry.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest stem cell manufacturing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American region is experiencing robust growth in the stem cell manufacturing market, propelled by the substantial government funding and private investments in stem cell research and regenerative medicine. These financial commitments support cutting-edge research, clinical trials, and the development of advanced manufacturing techniques. Moreover, the prevalence of chronic diseases, such as diabetes, heart disease, and neurodegenerative disorders, is on the rise in North America. Stem cell therapies offer innovative solutions to address these conditions, fueling demand for their production. In line with this, the region boasts a highly developed biotechnology sector, leading to significant advancements in cell culture techniques and bioprocessing technologies. This ensures efficient and scalable stem cell production, strengthening the industry's foothold in North America. Furthermore, regulatory frameworks in North America provide a conducive environment for stem cell research and clinical trials, fostering growth and innovation. Collaborative efforts between academic institutions and industry players, along with growing public awareness of the potential of stem cell-based treatments, are additional drivers.

Competitive Landscape:

The competitive landscape within the global stem cell manufacturing market is characterized by a dynamic interplay of numerous players, each vying to establish their prominence and contribute to the industry's growth. These entities span a spectrum of organizations, including research institutions, biotechnology companies, pharmaceutical giants, and contract manufacturing organizations. Their diverse backgrounds and resources contribute to a multifaceted ecosystem that fosters innovation and advancements in stem cell manufacturing. Key competitive strategies encompass research and development efforts to enhance manufacturing processes, scale up production, and improve the quality and safety of stem cell-based therapies. Additionally, partnerships and collaborations between these players are common, facilitating knowledge sharing and the development of cutting-edge technologies. For instance, in June 2021, Catalent, in a strategic move, acquired RheinCell Therapeutics Gmbh for an undisclosed amount to expand the creation of advanced cell treatments, thereby enhancing Catalent's capacity for large-scale production. Regulatory compliance and adherence to ethical standards are pivotal in maintaining credibility within the market. Moreover, market participants often engage in marketing and educational initiatives to increase awareness of stem cell therapies among healthcare professionals and the public, further expanding their reach.

The report provides a comprehensive analysis of the competitive landscape in the global stem cell manufacturing market with detailed profiles of all major companies, including:

  • AcceGen
  • Bio-Rad Laboratories, Inc.
  • Cellular Engineering Technologies, Inc
  • Corning Incorporated
  • Lonza Group AG
  • REPROCELL Inc
  • Sartorius AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global stem cell manufacturing market in 2025?

2. What is the expected growth rate of the global stem cell manufacturing market during 2026-2034?

3. What are the key factors driving the global stem cell manufacturing market?

4. What has been the impact of COVID-19 on the global stem cell manufacturing market?

5. What is the breakup of the global stem cell manufacturing market based on product?

6. What is the breakup of the global stem cell manufacturing market based on the application?

7. What is the breakup of the global stem cell manufacturing market based on the end user?

8. What are the key regions in the global stem cell manufacturing market?

9. Who are the key players/companies in the global stem cell manufacturing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Stem Cell Manufacturing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Culture Media
      • 6.1.2.2 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Bioreactors and Incubators
      • 6.2.2.2 Cell Sorters
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast
  • 6.3 Stem Cell Lines
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Hematopoietic Stem Cells (HSC)
      • 6.3.2.2 Mesenchymal Stem Cells (MSC)
      • 6.3.2.3 Induced Pluripotent Stem Cells (iPSC)
      • 6.3.2.4 Embryonic Stem Cells (ESC)
      • 6.3.2.5 Neural Stem Cells (NSC)
      • 6.3.2.6 Multipotent Adult Progenitor Stem Cells
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Research Applications
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Life Science Research
      • 7.1.2.2 Drug Discovery and Development
    • 7.1.3 Market Forecast
  • 7.2 Clinical Application
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Allogenic Stem Cell Therapy
      • 7.2.2.2 Autologous Stem Cell Therapy
    • 7.2.3 Market Forecast
  • 7.3 Cell and Tissue Banking Applications
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical & Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic Institutes, Research Laboratories and Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hospitals and Surgical Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cell and Tissue banks
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AcceGen
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bio-Rad Laboratories, Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cellular Engineering Technologies, Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Corning Incorporated
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Lonza Group AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 REPROCELL Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sartorius AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Takara Bio Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Thermo Fisher Scientific Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Stem Cell Manufacturing Market: Major Drivers and Challenges
  • Figure 2: Global: Stem Cell Manufacturing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Stem Cell Manufacturing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Stem Cell Manufacturing Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Stem Cell Manufacturing Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Stem Cell Manufacturing Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Stem Cell Manufacturing Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Stem Cell Manufacturing (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Stem Cell Manufacturing (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Stem Cell Manufacturing (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Stem Cell Manufacturing (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Stem Cell Manufacturing (Stem Cell Lines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Stem Cell Manufacturing (Stem Cell Lines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Stem Cell Manufacturing (Research Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Stem Cell Manufacturing (Research Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Stem Cell Manufacturing (Clinical Application) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Stem Cell Manufacturing (Clinical Application) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Stem Cell Manufacturing (Cell and Tissue Banking Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Stem Cell Manufacturing (Pharmaceutical & Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Stem Cell Manufacturing (Academic Institutes, Research Laboratories and Contract Research Organizations) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Stem Cell Manufacturing (Hospitals and Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Stem Cell Manufacturing (Cell and Tissue banks) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Stem Cell Manufacturing (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Stem Cell Manufacturing (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: North America: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: North America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: United States: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: United States: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Canada: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Canada: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Asia-Pacific: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Asia-Pacific: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: China: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: China: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Japan: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Japan: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: India: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: India: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: South Korea: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: South Korea: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Australia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Australia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Indonesia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Indonesia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Europe: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Europe: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Germany: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Germany: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: France: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: France: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: United Kingdom: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: United Kingdom: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Italy: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Italy: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Spain: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Spain: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Russia: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Russia: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Latin America: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Latin America: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Brazil: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Brazil: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Mexico: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Mexico: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Others: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Others: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Middle East and Africa: Stem Cell Manufacturing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Middle East and Africa: Stem Cell Manufacturing Market: Breakup by Country (in %), 2025
  • Figure 78: Middle East and Africa: Stem Cell Manufacturing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Stem Cell Manufacturing Industry: SWOT Analysis
  • Figure 80: Global: Stem Cell Manufacturing Industry: Value Chain Analysis
  • Figure 81: Global: Stem Cell Manufacturing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Stem Cell Manufacturing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Stem Cell Manufacturing Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Stem Cell Manufacturing Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Stem Cell Manufacturing Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Stem Cell Manufacturing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Stem Cell Manufacturing Market: Competitive Structure
  • Table 7: Global: Stem Cell Manufacturing Market: Key Players